Literature DB >> 26835038

Mimics of Hypertrophic Cardiomyopathy - Diagnostic Clues to Aid Early Identification of Phenocopies.

Rajiv Sankaranarayanan1, Eleanor J Fleming2, Clifford J Garratt1.   

Abstract

Hypertrophic cardiomyopathy (HCM) is the most common genetic cause of cardiomyopathy worldwide. Significant advances and widespread availability of genetic testing have improved detection of the sarcomeric mutations that cause HCM, but have also highlighted the significance of inborn errors of metabolism (IEM) or metabolic storage disorders that can mimic HCM ('HCM phenocopies'). These conditions cannot always be reliably differentiated on the basis of imaging alone. Whilst HCM phenocopies are relatively rare, it is crucial to distinguish these conditions at an early stage as their natural history, management and prognosis vary significantly from that of HCM with sarcomeric mutations. This review illustrates the salient features of HCM phenocopies and stresses the need for a high level of suspicion for these conditions in the assessment of cardiac hypertrophy.

Entities:  

Keywords:  Hypertrophic cardiomyopathy; genetic testing; metabolic storage disorders; phenocopies; sarcomeric mutations

Year:  2013        PMID: 26835038      PMCID: PMC4711498          DOI: 10.15420/aer.2013.2.1.36

Source DB:  PubMed          Journal:  Arrhythm Electrophysiol Rev        ISSN: 2050-3369


  38 in total

Review 1.  New approaches to the clinical diagnosis of inherited heart muscle disease.

Authors:  Luis Rocha Lopes; Perry Mark Elliott
Journal:  Heart       Date:  2013-03-06       Impact factor: 5.994

2.  Lysosomal glycogen storage disease with normal acid maltase.

Authors:  M J Danon; S J Oh; S DiMauro; J R Manaligod; A Eastwood; S Naidu; L H Schliselfeld
Journal:  Neurology       Date:  1981-01       Impact factor: 9.910

3.  Discrimination of nonobstructive hypertrophic cardiomyopathy from hypertensive left ventricular hypertrophy on the basis of strain rate imaging by tissue Doppler ultrasonography.

Authors:  Tomoko S Kato; Akiko Noda; Hideo Izawa; Akira Yamada; Koji Obata; Kohzo Nagata; Mitsunori Iwase; Toyoaki Murohara; Mitsuhiro Yokota
Journal:  Circulation       Date:  2004-12-06       Impact factor: 29.690

Review 4.  Mechanisms of disease: hypertrophic cardiomyopathy.

Authors:  Norbert Frey; Mark Luedde; Hugo A Katus
Journal:  Nat Rev Cardiol       Date:  2011-10-25       Impact factor: 32.419

Review 5.  Cardiomyopathy in Pompe's disease.

Authors:  A Fayssoil
Journal:  Eur J Intern Med       Date:  2007-11-26       Impact factor: 4.487

6.  Histologic characterization of hypertrophic cardiomyopathy with and without myofilament mutations.

Authors:  Christopher J McLeod; J Martijn Bos; Jeanne L Theis; William D Edwards; Bernard J Gersh; Steve R Ommen; Michael J Ackerman
Journal:  Am Heart J       Date:  2009-10-03       Impact factor: 4.749

Review 7.  Clinicopathological features of genetically confirmed Danon disease.

Authors:  K Sugie; A Yamamoto; K Murayama; S J Oh; M Takahashi; M Mora; J E Riggs; J Colomer; C Iturriaga; A Meloni; C Lamperti; S Saitoh; E Byrne; S DiMauro; I Nonaka; M Hirano; I Nishino
Journal:  Neurology       Date:  2002-06-25       Impact factor: 9.910

8.  Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey.

Authors:  A Mehta; R Ricci; U Widmer; F Dehout; A Garcia de Lorenzo; C Kampmann; A Linhart; G Sunder-Plassmann; M Ries; M Beck
Journal:  Eur J Clin Invest       Date:  2004-03       Impact factor: 4.686

9.  Advantages of a subcutaneous implantable cardioverter-defibrillator in LAMP2 hypertrophic cardiomyopathy.

Authors:  Aly Zaki; Amir Zaidi; William G Newman; Clifford J Garratt
Journal:  J Cardiovasc Electrophysiol       Date:  2013-04-11

10.  Natural history of Danon disease.

Authors:  Dana Boucek; Jean Jirikowic; Matthew Taylor
Journal:  Genet Med       Date:  2011-06       Impact factor: 8.822

View more
  10 in total

Review 1.  Hypertrophic Cardiomyopathy: Genetic Testing and Risk Stratification.

Authors:  Fergus Stafford; Kate Thomson; Alexandra Butters; Jodie Ingles
Journal:  Curr Cardiol Rep       Date:  2021-01-12       Impact factor: 2.931

2.  Stress Myocardial Blood Flow Heterogeneity Is a Positron Emission Tomography Biomarker of Ventricular Arrhythmias in Patients With Hypertrophic Cardiomyopathy.

Authors:  Dai-Yin Lu; Hulya Yalçin; Fatih Yalçin; Min Zhao; Sanjay Sivalokanathan; Ines Valenta; Abdel Tahari; Martin G Pomper; Theodore P Abraham; Thomas H Schindler; M Roselle Abraham
Journal:  Am J Cardiol       Date:  2018-02-06       Impact factor: 2.778

Review 3.  Genetics of hypertrophic cardiomyopathy: advances and pitfalls in molecular diagnosis and therapy.

Authors:  Catarina Roma-Rodrigues; Alexandra R Fernandes
Journal:  Appl Clin Genet       Date:  2014-10-03

4.  Diagnostic Clues for the Diagnosis of Nonsarcomeric Hypertrophic Cardiomyopathy (Phenocopies): Amyloidosis, Fabry Disease, and Mitochondrial Disease.

Authors:  Giuseppe Limongelli; Daniele Masarone; Marina Verrengia; Rita Gravino; Gemma Salerno; Silvia Castelletti; Marta Rubino; Tommaso Marrazzo; Antonio Pisani; Franco Cecchi; Perry Mark Elliott; Giuseppe Pacileo
Journal:  J Cardiovasc Echogr       Date:  2018 Apr-Jun

Review 5.  Cardiomyopathies and Related Changes in Contractility of Human Heart Muscle.

Authors:  Petr G Vikhorev; Natalia N Vikhoreva
Journal:  Int J Mol Sci       Date:  2018-07-31       Impact factor: 5.923

6.  Treatment of Severe Left Ventricular Outflow Tract Obstruction and Mitral Regurgitation With Alcohol Septal Ablation.

Authors:  Michael Morcos; Aaron Strobel; John Messenger; Edward Gill
Journal:  CASE (Phila)       Date:  2022-08-08

7.  Machine Learning Methods for Identifying Atrial Fibrillation Cases and Their Predictors in Patients With Hypertrophic Cardiomyopathy: The HCM-AF-Risk Model.

Authors:  Moumita Bhattacharya; Dai-Yin Lu; Ioannis Ventoulis; Gabriela V Greenland; Hulya Yalcin; Yufan Guan; Joseph E Marine; Jeffrey E Olgin; Stefan L Zimmerman; Theodore P Abraham; M Roselle Abraham; Hagit Shatkay
Journal:  CJC Open       Date:  2021-02-02

Review 8.  Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing?

Authors:  Francesco Mazzarotto; Iacopo Olivotto; Beatrice Boschi; Francesca Girolami; Corrado Poggesi; Paul J R Barton; Roddy Walsh
Journal:  J Am Heart Assoc       Date:  2020-04-18       Impact factor: 5.501

Review 9.  Differential diagnosis of thickened myocardium: an illustrative MRI review.

Authors:  Cristina Méndez; Rafaela Soler; Esther Rodríguez; Roberto Barriales; Juan Pablo Ochoa; Lorenzo Monserrat
Journal:  Insights Imaging       Date:  2018-10-09

Review 10.  Look Alike, Sound Alike: Phenocopies in Steroid-Resistant Nephrotic Syndrome.

Authors:  Francesca Becherucci; Samuela Landini; Luigi Cirillo; Benedetta Mazzinghi; Paola Romagnani
Journal:  Int J Environ Res Public Health       Date:  2020-11-12       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.